Today: 28 June 2026
Browse Category

Cannabis Industry 7 December 2025 - 16 June 2026

IM Cannabis Stock Surges as Traders Weigh Nasdaq Listing and Dilution Risks

IM Cannabis Stock Surges as Traders Weigh Nasdaq Listing and Dilution Risks

IM Cannabis surged over 12% to $0.2610 with premarket quotes at $0.3491 amid high volume and no new company news, as investors eye risks from a recent resale-registration filing covering 17.3 million shares and Nasdaq’s $1.00 bid-price deadline; full conversion could boost shares outstanding by 306%, raising dilution concerns and potential stock pressure.
16 June 2026
···
Tilray Brands (TLRY) stock jumps in premarket after record $218 mln quarter and net cash turn

Tilray Brands (TLRY) stock jumps in premarket after record $218 mln quarter and net cash turn

Tilray shares jumped nearly 9% to $9.95 in premarket trading after reporting fiscal Q2 revenue of $217.5 million and a narrowed net loss of $43.5 million. The company reaffirmed its full-year adjusted profit target and said it moved to a net cash position. Gross margin slipped, and craft beer sales remained under pressure. Traders are watching if the gains hold at the open.
9 January 2026
··
Canopy Growth (CGC) Stock on Dec. 24, 2025: Schedule III Executive Order, MTL Cannabis Deal, and the Latest Forecasts

Canopy Growth (CGC) Stock on Dec. 24, 2025: Schedule III Executive Order, MTL Cannabis Deal, and the Latest Forecasts

Canopy Growth shares closed at $1.40 on Dec. 23, up 6.06%, after heavy trading and sharp swings throughout December. The volatility followed a Dec. 18 White House executive order directing marijuana rescheduling from Schedule I to III. Trading volume spiked to over 216 million shares on Dec. 18, with implied volatility near 143%. U.S. exchanges operated a shortened session on Dec. 24.
24 December 2025
····
Tilray Brands (TLRY) Stock News Today: Cannabis Rescheduling, Earnings Date, Reverse Split, and Analyst Forecasts (Dec. 24, 2025)

Tilray Brands (TLRY) Stock News Today: Cannabis Rescheduling, Earnings Date, Reverse Split, and Analyst Forecasts (Dec. 24, 2025)

Tilray Brands shares traded near $10.53 on December 24, 2025, following sharp gains in the second half of the year. President Donald Trump signed an executive order on December 18 to begin the process of reclassifying marijuana from Schedule I to Schedule III. The move sparked volatility across cannabis stocks, with prices swinging as investors weighed the potential impact. The order does not legalize cannabis but directs federal agencies to review its status.
24 December 2025
··
Tilray Brands (TLRY) Stock News Today: Trump Cannabis Rescheduling Reports Fuel Volatility, Fresh Forecasts and Key Levels (Dec. 17, 2025)

Tilray Brands (TLRY) Stock News Today: Trump Cannabis Rescheduling Reports Fuel Volatility, Fresh Forecasts and Key Levels (Dec. 17, 2025)

Tilray Brands shares jumped 27% to $13.94 on December 17, 2025, amid reports President Donald Trump may soon sign an executive order to reclassify marijuana at the federal level. The stock swung between $10.32 and $14.54 during the session. Reuters and NBC News cited sources saying the move could come this week. No final decision has been made, according to a White House spokesperson.
17 December 2025
···
S&P/TSX Composite Today: Oil Slips Toward $60, Cannabis Surges, and Macklem’s Speech Looms for After-the-Bell Trade (Dec. 16, 2025)

S&P/TSX Composite Today: Oil Slips Toward $60, Cannabis Surges, and Macklem’s Speech Looms for After-the-Bell Trade (Dec. 16, 2025)

Canada’s S&P/TSX Composite index fell about 0.5% to 31,324 in late-morning trading Tuesday, led by a 3% drop in energy stocks as oil prices slid below $60 on Russia–Ukraine peace hopes. Weak Chinese economic data and oversupply concerns added pressure. Cannabis stocks rose after U.S. President Trump floated marijuana reclassification. Organigram reported record results, boosting sector sentiment.
16 December 2025
··
Tilray Brands (TLRY) Stock News Today: Cannabis Rally Cools as Trump Schedule III Speculation Fuels Volatility

Tilray Brands (TLRY) Stock News Today: Cannabis Rally Cools as Trump Schedule III Speculation Fuels Volatility

Tilray shares fell about 7% to $11.30 in late trading December 15, reversing some of last week’s 65% rally. The surge and pullback followed reports that Donald Trump may push to reclassify cannabis to Schedule III, but the White House signaled no decision is final. Uncertainty over timing and scope cooled investor appetite across the cannabis sector.
15 December 2025
··
Tilray Stock Surges as Trump Schedule III Buzz Collides With New Vape Launch and Reverse Split Fallout

Tilray Stock Surges as Trump Schedule III Buzz Collides With New Vape Launch and Reverse Split Fallout

Tilray Brands shares surged December 15 as global cannabis stocks rallied on reports that Donald Trump may push to reclassify marijuana as a Schedule III drug. The move, which would ease federal restrictions but stop short of legalization, fueled investor optimism over potential tax and banking benefits for the industry. Tilray also completed a 1-for-10 reverse stock split and reported momentum in its Canadian portfolio.
15 December 2025
····
Canopy Growth Corporation Stock (CGC) Surges on Trump Marijuana Rescheduling Reports: Latest News, Forecasts, and What Comes Next (Dec. 15, 2025)

Canopy Growth Corporation Stock (CGC) Surges on Trump Marijuana Rescheduling Reports: Latest News, Forecasts, and What Comes Next (Dec. 15, 2025)

Canopy Growth shares surged as much as 17.9% in early European trading Monday, extending Friday’s 54% jump, after reports that President Trump may reclassify marijuana as a Schedule III drug. Trading volume spiked, with speculation focused on potential U.S. federal reform and its impact on cannabis industry taxes. No final decision has been confirmed by the White House.
15 December 2025
··
Tilray Brands (TLRY) Stock: What to Know Before the U.S. Market Opens on Dec. 15, 2025

Tilray Brands (TLRY) Stock: What to Know Before the U.S. Market Opens on Dec. 15, 2025

Tilray Brands shares surged 44% to $12.15 Friday after reports that President Trump may direct agencies to reclassify marijuana as a Schedule III drug. Volume reached 84.2 million shares, with prices swinging between $10.32 and $13.85. The move follows Tilray’s 1-for-10 reverse stock split effective Dec. 2. Timing of any federal action remains uncertain.
14 December 2025
···
Tilray Brands (TLRY) Stock Jumps on Marijuana Rescheduling Buzz: This Week’s Move, Latest News, and Week-Ahead Outlook (Updated Dec. 12, 2025)

Tilray Brands (TLRY) Stock Jumps on Marijuana Rescheduling Buzz: This Week’s Move, Latest News, and Week-Ahead Outlook (Updated Dec. 12, 2025)

Tilray Brands (TLRY) soared 44% to $12.15 on Dec. 12, with trading volume reaching 81.58 million shares after reports that Donald Trump may push to loosen federal marijuana restrictions. Shares gained nearly 69% for the week. After hours, TLRY traded as high as $13.14. The White House said no final decision has been made on marijuana rescheduling.
13 December 2025
··
Top Stock Gainers Today (Dec. 12, 2025, 12:30 p.m. ET): cbdMD, Canopy Growth, Tilray Lead a Cannabis-Fueled Rally

Top Stock Gainers Today (Dec. 12, 2025, 12:30 p.m. ET): cbdMD, Canopy Growth, Tilray Lead a Cannabis-Fueled Rally

cbdMD (YCBD) surged 126.6% to $1.43 by 12:30 p.m. ET, leading US stock gainers amid reports President Trump may ease federal marijuana restrictions. Major indexes fell, with the S&P 500 down 1.05% and Nasdaq 100 off 1.8%. Small-cap and cannabis stocks outperformed on policy speculation and company news.
12 December 2025
····
Cronos Group Inc (CRON) Stock Surges as US Marijuana Rescheduling Buzz Returns — Latest News, Forecasts, and Key Catalysts (Dec. 12, 2025)

Cronos Group Inc (CRON) Stock Surges as US Marijuana Rescheduling Buzz Returns — Latest News, Forecasts, and Key Catalysts (Dec. 12, 2025)

Cronos Group shares jumped as much as 19% in premarket trading Dec. 12 after reports that President Trump may seek to reclassify marijuana as a Schedule III drug. Reuters and other outlets cited broad gains across cannabis stocks on the news. Cronos recently announced a strategic acquisition in the Netherlands, aiming for top market share in Europe's largest adult-use market. No final decisions on U.S. policy have been confirmed.
12 December 2025
··
Canopy Growth Corporation Stock (CGC) Jumps on Trump Marijuana Rescheduling Report — News, Forecasts, and What Investors Are Watching (Dec. 12, 2025)

Canopy Growth Corporation Stock (CGC) Jumps on Trump Marijuana Rescheduling Report — News, Forecasts, and What Investors Are Watching (Dec. 12, 2025)

Canopy Growth shares jumped about 21% in premarket trading Friday after reports said President Trump is expected to direct federal agencies to reclassify marijuana as a Schedule III drug. The move, first reported by the Washington Post and cited by Reuters, triggered a surge across US-listed cannabis stocks. No final decision has been made, according to a White House official.
12 December 2025
····
Tilray Brands (TLRY) Stock Jumps on Trump Marijuana Rescheduling Report: Latest News, Forecasts, and Analyst Views (Dec. 12, 2025)

Tilray Brands (TLRY) Stock Jumps on Trump Marijuana Rescheduling Report: Latest News, Forecasts, and Analyst Views (Dec. 12, 2025)

Tilray Brands shares surged 28% in premarket trading on December 12, 2025, after reports that President Trump may push to reclassify marijuana as a Schedule III substance. The move sparked a rally across cannabis stocks. The Washington Post said no final decision had been made, according to a White House official.
12 December 2025
···
US Stock Market Premarket Top Gainers Today (Dec. 12, 2025): Lululemon Surges, Cannabis Stocks Rally, Mitek and Quanex Jump

US Stock Market Premarket Top Gainers Today (Dec. 12, 2025): Lululemon Surges, Cannabis Stocks Rally, Mitek and Quanex Jump

cbdMD jumped 39.9% premarket after announcing it regained full compliance with NYSE American listing standards. Kaival Brands surged 56.5%, Neo-Concept International rose 46%, and Tilray Brands gained 30.3%. US stock futures were mixed early Friday as investors weighed Fed policy and tech sector spending.
12 December 2025
·············
Tilray Brands (TLRY) Soars After Reverse Stock Split and Cannabis Bill Hopes: Stock Forecast, Price Targets and 2026 Outlook

Tilray Brands (TLRY) Soars After Reverse Stock Split and Cannabis Bill Hopes: Stock Forecast, Price Targets and 2026 Outlook

Tilray Brands shares surged 12.4% to $8.09 on December 9, 2025, after weeks of steep declines and heavy trading volume. The rebound followed news of a Florida bill to allow home cannabis cultivation and renewed speculation over U.S. federal rescheduling. Tilray remains down 65% from its October high and recently completed a 1-for-10 reverse stock split.
10 December 2025
···
Aurora Cannabis (ACB) Stock on December 7, 2025: Australia Deal, Q2 2026 Earnings and What Forecasts Say Next

Aurora Cannabis (ACB) Stock on December 7, 2025: Australia Deal, Q2 2026 Earnings and What Forecasts Say Next

Aurora Cannabis shares traded near US$4.60 on NASDAQ and C$6.39 on TSX as of early December, valuing the company at about US$260–280 million. The stock remains volatile, with a 34% drop from its February high but up 12–13% over the last 10 sessions. On December 2, Aurora’s MedReleaf Australia signed a distribution deal with Leafio, expanding access to over 4,000 pharmacies nationwide.
7 December 2025
···
1 2

Stock Market Today

  • Nancy Pelosi Adds 9 Stocks to Portfolio Since 2025 Including Magnificent Seven Names
    June 28, 2026, 2:01 PM EDT. Congresswoman Nancy Pelosi has disclosed adding nine stocks to her portfolio since 2025, including three Magnificent Seven technology giants: Amazon, Nvidia, and Alphabet. Her trades include purchasing and exercising call options-contracts giving the right to buy shares at set prices-across sectors, mainly technology and large-cap stocks. Pelosi's husband, Paul Pelosi, likely manages the trades, known for buying in-the-money call options with lengthy expiration dates and exercising them into common shares. Recent acquisitions include Vistra Corporation, Tempus AI, Broadcom, AllianceBernstein Holdings, Intel, and Uber Technologies, totaling about $8.88 million in transactions in 2026. This activity reflects a strategic, high-value approach focusing on prominent tech companies and blue-chip equities.

Latest articles

BlackBerry shares surge by $1.6 billion on QNX value, government business cools

BlackBerry shares surge by $1.6 billion on QNX value, government business cools

28 June 2026
BlackBerry soared 32.3% in two days to a four-and-a-half-year high as Secure Communications topped QNX in Q1 revenue and adjusted EBITDA, but the fiscal 2027 revenue midpoint rose just $10 million; shares closed Friday at $11.40, 14% above the average analyst target, with analysts and management signaling QNX growth will be gradual, not immediate.
AT&T shares dip as fiber build-out runs into legacy line disputes

AT&T (NYSE:T) gets cash bid after low spectrum spend, dividend date set for July

28 June 2026
AT&T jumped 3.2% to $22.72 since June 18 as investors cheered its minimal $120.77 million AWS-3 spectrum auction spend—just 0.7% of 2026 free cash flow—while rivals Verizon and T-Mobile spent billions; Friday’s trading volume hit 199% of average, and AT&T reaffirmed $18 billion-plus free cash flow and $8 billion in buybacks for 2026.
Keurig Dr Pepper moves on dividend talk as volume climbs before split trial

Keurig Dr Pepper moves on dividend talk as volume climbs before split trial

28 June 2026
Keurig Dr Pepper surged to $33.40 Friday with a 54.8 million share volume—428% of average—after going ex-dividend, outpacing peers as the S&P 500 fell; the spike, making up 45% of weekly trading, coincided with short interest at 5.16% of float and management changes, while KDP reaffirmed 2026 sales and earnings guidance.
Energy stocks this week: U.S. sector ETF holds flat as oil falls

Energy stocks this week: U.S. sector ETF holds flat as oil falls

28 June 2026
Brent crude plunged 10.86% last week as Hormuz flows improved, but the Energy Select Sector SPDR Fund (XLE) fell just 0.4%, signaling investors are no longer trading energy stocks in lockstep with oil prices; this divergence matters now as refiners benefit from tight diesel margins while oilfield services face risks from a Norway lockout and rising U.S. rigs.
Go toTop